Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FXYD6-FXYD2 - HIV-1 Vpr effect on monocyte-derived macrophage
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FXYD2 - HIV-1 Vpr effect on monocyte-derived macrophage
FXYD6-FXYD2 - Clear-cell renal cell carcinoma tumors and tumorgrafts deficient for tumor suppressor BAP1 or PBRM1
FXYD2 - Clear-cell renal cell carcinoma tumors and tumorgrafts deficient for tumor suppressor BAP1 or PBRM1
FXYD6-FXYD2 - In vitro expanded and re-differentiated pancreatic islet cells
FXYD2 - In vitro expanded and re-differentiated pancreatic islet cells
FXYD2 - Pancreatic beta cells and panel of primary tissues
FXYD2 - NOTCH antagonist SAHM1 effect on T-ALL cell lines
FXYD6-FXYD2 - Chromophobe renal cell carcinoma and oncocytoma
FXYD2 - Chromophobe renal cell carcinoma and oncocytoma
FXYD2 - Various normal tissues
FXYD2 - Autism, fragile X syndrome, and 15q11-q13 duplication: lymphoblastoid cells
FXYD6-FXYD2 - Kidney transplant rejection expression profiling
FXYD2 - High-grade serous ovarian cancer resistant to platinum-based chemotherapy
FXYD2 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
FXYD6-FXYD2 - PICALM-MLLT10 positive acute leukemia: mononuclear cells
FXYD2 - PICALM-MLLT10 positive acute leukemia: mononuclear cells
FXYD2 - Early T-cell precursor acute lymphoblastic leukemia
FXYD6-FXYD2 - Inhibition of Notch signaling in T cell acute lymphoblastic leukemia cell lines
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on